Thus, further studies are required to examine whetherelevated CRP levels in patients with recent MI confer an adverse prognosis afterrevascularization, and CRP levels should be put in context with myocardial injurybiomarkers (troponin, cardiac creatine kinase—discussed later in this work).Indeed, high CRP levels reflect the systemic atherosclerotic inflammation and theatherosclerosis burden of the patient. The gene discussed is CRP; the disease is myocardial infarction.